Graphene-Based Devices Face Regulation Questions In Europe

Medtech Insight spoke to two CEOs of start-ups working on graphene-based devices to learn more about how regulation and fears over nanomaterials’ side effects affect device development.

• Source: Alamy

More from Diagnostics

More from Device Area